Liquidia Corporation is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Roger A. Jeffs, with a market cap of $3.6B.
Common questions about Liquidia Corporation
Liquidia Corporation is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $113.5M.
Liquidia Corporation has approximately 145 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.